AU: 65 Roses campaign raised over $50,000 for Cystic Fibrosis

May is the month dedicated to raising awareness of Cystic Fibrosis (CF) internationally. As part of the ’65 Roses’ campaign, this year’s 65 Roses Day took place on Friday 27 May. Over 11,000 stems of roses were sold, which raised over $50,000 AUD to provide care to children and young adults living with CF and to fund research that will one day find a cure for this disease. Australian cut flower company WAFEX helped raise the money this day.

Cystic Fibrosis is a genetic disease, which affects nearly 4,000 children and young adults living in Australia. It is as common as childhood leukaemia, but whereas over 95% of cases of childhood Leukaemia are cured, there is still no cure for CF.

Businesses and volunteers have rallied around the campaign to help raise funds and increase awareness for this disease.

WAFEX, Australia’s leading importer of fresh roses began their relationship with Cystic Fibrosis over eight years ago when former WAFEX Director, Adrian Parsons observed that 65 Roses Day fundraising did not involve fresh roses.

After initiating a number of fundraising activities involving fresh roses, WAFEX now supports all Cystic Fibrosis WA (CFWA) fundraising and events throughout the year, including the donation and supply of fresh roses for 65 Roses Day.

WAFEX National Manager, Daniel Stean says, “We are delighted that we partnered with Cystic Fibrosis WA for 65 Roses Day. It’s an excellent platform to raise funds for an important charity along with bringing the beauty of fresh roses to the general public.”

CFWA CEO, Nigel Barker says, “Our organisation greatly appreciates the strong, ongoing sponsorship from WAFEX that will help us achieve this sum of money.”

Roses for 65 Roses Day were sold by CFWA volunteers at $5 per stem, or $50 for 12 roses, throughout Western Australia.

For more information:

Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.

Click here for a guide on disabling your adblocker.